2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
2008 Barcelona - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Molecular and biochemical basis <strong>of</strong> disease<br />
control groups. Statistical analysis showed significant association between<br />
A to G mutation and risk <strong>of</strong> atherosclerosis (P = 0.01). No significant<br />
alteration in the level <strong>of</strong> total bilirubin was observed between case<br />
and control groups (P = 0.6). This is the first report on the association<br />
between HMOX2 and atherosclerosis among Iranian CAD patients .<br />
This finding presences the importance <strong>of</strong> this mutation in development<br />
<strong>of</strong> atherosclerosis . More study would show the importance <strong>of</strong> hemoxygenase<br />
2 gene mutation in other populations .<br />
P06.032<br />
Large scale association study <strong>of</strong> gene-gene interaction within<br />
the filaggrin pathway<br />
E. Rodríguez 1 , H. Baurecht 1 , N. Novak 2 , N. Klopp 3 , T. Illig 3 , S. Wagenpfeil 1 , A.<br />
D. Irvine 4 , S. Weidinger 1 ;<br />
1 Technical University Munich, Munich, Germany, 2 University <strong>of</strong> Bonn, Bonn,<br />
Germany, 3 Helmholtz Zentrum München, Neuherberg, Germany, 4 Our Lady’s<br />
Children’s Hospital, Dublin, Ireland.<br />
Filaggrin deficiency due to null mutations in the FLG gene has been<br />
established as risk factor for atopic eczema (AE) . Processing <strong>of</strong> pr<strong>of</strong>ilaggrin<br />
to biologically active filaggrin monomers involves several dephosphorylation<br />
and proteolytic steps, and their impairment might also<br />
disturb skin barrier function . Among the proteases suggested to be<br />
implicated in pr<strong>of</strong>ilaggrin processing is the stratum corneum chymotryptic<br />
enzyme (SCCE), which is possibly regulated by SPINK5-derived<br />
serine proteinase inhibitor LEKTI. An insertion in the 3′ untranslated<br />
region <strong>of</strong> the kallikrein 7 gene (KLK7) encoding SCCE as well as<br />
a SPINK5 variant have been reported to be associated with AE, but<br />
could not be replicated so far .<br />
In our study we aimed at clarifying the role <strong>of</strong> these genetic variants for<br />
AE. Considering the potential biological interactions between filaggrin,<br />
SSCE and LEKTI, we also examined gene-gene interactions .<br />
Association analysis was carried out in a cohort <strong>of</strong> 486 German families<br />
as well as in a cohort <strong>of</strong> 773 cases and 2924 supernormal controls .<br />
Whereas the strong effect <strong>of</strong> FLG polymorphisms was confirmed, no<br />
association <strong>of</strong> the KLK7 insertion could be detected . Concerning the<br />
SPINK5 polymorphism rs2303067 A-allele, weak association was observed<br />
in the family collection only, with a strong maternal effect . There<br />
was no evidence for epistatic effects between FLG, KLK7, and SPINK5<br />
variants that significantly predict AE risk. Thus, our data confirm the<br />
impact <strong>of</strong> filaggrin deficiency due to FLG loss-<strong>of</strong>-function mutations on<br />
AE risk, but do not support the hypothesis that this effect is dependent<br />
on KLK7 or SPINK5 .<br />
P06.033<br />
Linkage and linkage disequilibrium scan for autism in an<br />
extended pedigree from Finland<br />
H. Kilpinen 1 , T. Ylisaukko-oja 1,2 , K. Rehnström 1,2 , E. Gaál 1 , J. A. Turunen 1 , E.<br />
Kempas 1 , L. von Wendt 3 , T. Varilo 1,2 , L. Peltonen 1,2,4 ;<br />
1 Department <strong>of</strong> Molecular Medicine, National Public Health Institute, Helsinki,<br />
Finland, 2 Department <strong>of</strong> Medical <strong>Genetics</strong>, University <strong>of</strong> Helsinki, Helsinki, Finland,<br />
3 Unit <strong>of</strong> Child Neurology, Hospital for Children and Adolescents, Helsinki,<br />
Finland, 4 Wellcome Trust Sanger Institute, Cambridge, United Kingdom.<br />
As a part <strong>of</strong> the genetic study <strong>of</strong> autism spectrum disorders (ASDs)<br />
in the Finnish population, an extensive genealogical search was conducted<br />
to find out whether a substantial fraction <strong>of</strong> the families would<br />
share the same ancestral lineage . Based on this search back to the<br />
17th century, 18 ASD families (33 affected) were merged into one extended<br />
pedigree .<br />
We hypothesized that this pedigree could expose rare ASD gene(s)<br />
enriched to this internal subisolate, and performed a genome-wide<br />
scan using 1107 STS-markers (intermarker spacing ~3 .4cM) . A joint<br />
analysis <strong>of</strong> linkage and linkage disequilibrium was performed with<br />
Pseudomarker statistics and a traditional multipoint linkage analysis<br />
with Simwalk2 .<br />
Nine loci exceeded the chosen significance level <strong>of</strong> -log(p)>2.5. Of<br />
these, 1q21-23 (p=0 .00082) is one <strong>of</strong> the best loci in our previous genome-wide<br />
scans for autism and Asperger syndrome in Finland, while<br />
15q11-13 (p=0 .00081) is a well-recognized site for cytogenetic abnormalities<br />
associated with autism . Best multipoint linkage was observed<br />
at 19p13 [-log(p)=3 .57] .<br />
Regional candidate genes were chosen from these best loci at 1q23,<br />
15q12 and 19p13, and analyzed with SNPs using additional 126<br />
families with ASDs (281 affected). Most significant association was<br />
observed with five consecutive SNPs <strong>of</strong> ATP1A2 (1q23; p=0 .00055)<br />
and with eight consecutive SNPs within a TLE-gene cluster (19p13;<br />
p=0 .000078) . This association evidence was not detected using the<br />
nationwide sample, suggesting enrichment <strong>of</strong> these loci to our pedigree<br />
. We are currently performing a high-resolution analysis <strong>of</strong> the<br />
extent <strong>of</strong> shared chromosomal regions among the members <strong>of</strong> the<br />
pedigree with Illumina 317k platform .<br />
P06.034<br />
the BDNF receptor gene NTRK is a susceptibility gene for<br />
autism<br />
C. Correia 1,2 , I. Sousa 2 , I. Peixeiro 2 , L. Lourenço 2 , J. Almeida 3 , R. Lontro 3 , L.<br />
Galllagher 4,5 , M. Gill 4,5 , S. Ennis 6 , G. Oliveira 3 , A. M. Vicente 1,2 ;<br />
1 Instituto Nacional de Saúde Dr.Ricardo Jorge, Lisboa, Portugal, 2 Instituto<br />
Gulbenkian de Ciência, Oeiras, Portugal, 3 Hospital Pediátrico de Coimbra,<br />
Coimbra, Portugal, 4 Department <strong>of</strong> <strong>Genetics</strong>, Smurfit Institute, Trinity College,<br />
Dublin, Ireland, 5 Department <strong>of</strong> Psychiatry, Trinity College, Dublin, Ireland,<br />
6 School <strong>of</strong> Medicine and Medical Sciences, University College, Dublin, Ireland.<br />
Autism is a complex neurodevelopmental disorder likely determined by<br />
multiple genes . The NTRK2 gene encodes a receptor, TrkB, for neurotrophin<br />
4/5 and Brain-Derived Neurotrophic Factor (BDNF), which<br />
promotes neuronal differentiation and regulation <strong>of</strong> synaptic function<br />
in the developing and adult nervous system . Intriguing observations,<br />
such as increased BDNF levels in autistic children and NTRK2 mutations<br />
in children with developmental delays, raise the hypothesis that<br />
an abnormal function/expression <strong>of</strong> NTRK2 might be involved in autism<br />
. 38 tag SNPs, spanning the NTRK2 gene, were tested for association<br />
with autism in 323 Portuguese trios. We found significant<br />
transmission disequilibrium <strong>of</strong> alleles at three markers in introns 5-6<br />
and 15-16 (0 .011